Related Experiment Video

Updated: May 24, 2026

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Sulfasalazine for brain cancer fits

Harald Sontheimer, Richard J Bridges

    Expert Opinion on Investigational Drugs
    |March 13, 2012
    PubMed

    Insights

    Sulfasalazine effectively inhibits malignant brain tumor growth by targeting the cystine-glutamate antiporter (system Xc). This drug may serve as an adjuvant therapy for malignant gliomas, offering new treatment avenues.

    Area of Science:

    • Neuro-oncology
    • Cancer Biology
    • Pharmacology

    Background:

    • Malignant brain tumors, particularly gliomas, exhibit altered metabolism.
    • The cystine-glutamate antiporter (system Xc) plays a crucial role in glioma cell proliferation and survival.
    • System Xc is a potential therapeutic target for brain cancer treatment.

    Discussion:

    • Sulfasalazine, an established anti-inflammatory drug, demonstrates potent inhibition of system Xc.
    • Preclinical studies indicate sulfasalazine's efficacy in reducing tumor growth and associated seizures in brain tumor models.
    • These findings highlight the therapeutic potential of targeting system Xc in malignant gliomas.

    Key Insights:

    • System Xc is a critical mediator in malignant brain tumor progression.
    • Sulfasalazine exhibits anti-tumorigenic and anti-convulsant effects relevant to gliomas.
    • Targeting system Xc represents a promising strategy for novel brain cancer therapies.

    Outlook:

    • Further clinical investigation of sulfasalazine as an adjuvant therapy for malignant gliomas is warranted.
    • Development of more targeted therapies inhibiting system Xc could improve patient outcomes.
    • Understanding system Xc's role may uncover new biomarkers for glioma diagnosis and treatment response.

    More Related Videos

    Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells05:02

    Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

    Published on: February 4, 2021

    A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies10:13

    A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies

    Published on: November 7, 2015

    Related Concept Videos

    Drugs for Treatment of Ulcerative Colitis in IBD01:29

    Drugs for Treatment of Ulcerative Colitis in IBD

    Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    Cancer Therapies02:49

    Cancer Therapies

    Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
    However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Cancer02:18

    Cancer

    Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.